Torrent Pharmaceuticals Share Price
- Advice
- Hold
Start SIP in Torrent Pharmaceuticals
Start SIPTorrent Pharmaceuticals Performance
Day Range
- Low 3,138
- High 3,219
52 Week Range
- Low 1,955
- High 3,591
- Open Price3,201
- Previous Close3,201
- Volume274823
Torrent Pharmaceuticals F&O
Torrent Pharmaceuticals Investment Rating
-
Master Rating:
-
Torrent Pharmaceuticals Ltd. is a leading Indian pharmaceutical company, offering a wide range of branded and generic medicines. It focuses on therapeutic areas like cardiovascular, central nervous system, gastroenterology, and diabetes, serving both domestic and international markets. Torrent Pharmaceuticals has an operating revenue of Rs. 11,225.00 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 22% is great, ROE of 24% is exceptional. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 9% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -10% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 2,434 | 2,394 | 2,143 | 2,123 | 2,146 | 2,121 | 1,920 |
| Operating Expenses Qtr Cr | 1,513 | 1,539 | 1,427 | 1,422 | 1,410 | 1,384 | 1,342 |
| Operating Profit Qtr Cr | 921 | 899 | 716 | 701 | 736 | 737 | 578 |
| Depreciation Qtr Cr | 190 | 189 | 195 | 191 | 192 | 183 | 182 |
| Interest Qtr Cr | 54 | 64 | 67 | 69 | 77 | 90 | 94 |
| Tax Qtr Cr | 210 | 198 | 120 | 133 | 155 | 152 | 109 |
| Net Profit Qtr Cr | 460 | 469 | 410 | 297 | 327 | 323 | 219 |
Torrent Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹3,310.24
- 50 Day
- ₹3,332.12
- 100 Day
- ₹3,216.20
- 200 Day
- ₹2,952.98
- 20 Day
- ₹3,355.73
- 50 Day
- ₹3,401.65
- 100 Day
- ₹3,235.44
- 200 Day
- ₹2,930.94
Torrent Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 3,222.80 |
| Second Resistance | 3,261.45 |
| Third Resistance | 3,303.90 |
| RSI | 38.34 |
| MFI | 17.68 |
| MACD Single Line | -40.82 |
| MACD | -63.62 |
| Support | |
|---|---|
| First Support | 3,141.70 |
| Second Support | 3,099.25 |
| Third Supoort | 3,060.60 |
Torrent Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 278,455 | 14,515,859 | 52.13 |
| Week | 3,307,303 | 263,823,576 | 79.77 |
| 1 Month | 1,021,516 | 73,600,202 | 72.05 |
| 6 Month | 422,760 | 26,037,782 | 61.59 |
Torrent Pharmaceuticals Result Highlights
Torrent Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Torrent Pharmaceuticals Ltd. is a prominent pharmaceutical company in India, specializing in the development, manufacturing, and marketing of branded and generic medicines. The company focuses on key therapeutic areas such as cardiovascular, central nervous system (CNS), gastroenterology, diabetes, and pain management. With a strong presence in both domestic and international markets, Torrent Pharmaceuticals is committed to innovation, quality, and regulatory compliance. Its state-of-the-art research and manufacturing facilities ensure the production of high-quality medicines that improve patient outcomes. Torrent Pharmaceuticals' global footprint spans over 40 countries, making it a trusted name in the healthcare industry worldwide.| Market Cap | 108,321 |
| Sales | 9,138 |
| Shares in Float | 9.81 |
| No of funds | 844 |
| Yield | 0.87 |
| Book Value | 15.79 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | 23 |
| Alpha | 0.16 |
| Beta | 0.43 |
Torrent Pharmaceuticals Shareholding Pattern
| Owner Name | Sep-24 | Jun-24 | Mar-24 | Dec-23 |
|---|---|---|---|---|
| Promoters | 71.25% | 71.25% | 71.25% | 71.25% |
| Mutual Funds | 3.69% | 4.35% | 4.46% | 4.48% |
| Insurance Companies | 1.89% | 2% | 1.95% | 1.96% |
| Foreign Portfolio Investors | 14.46% | 14.22% | 14.14% | 14.08% |
| Financial Institutions/ Banks | 0.01% | |||
| Individual Investors | 4.34% | 3.98% | 4.08% | 4.15% |
| Others | 4.37% | 4.19% | 4.12% | 4.08% |
Torrent Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Sudhir Mehta | Chairman Emeritus |
| Mr. Samir Mehta | Executive Chairman |
| Mr. Aman Samir Mehta | Whole Time Director |
| Mr. Jinesh Shah | Director - Operations |
| Mr. Jinal Mehta | Non Executive Director |
| Mr. Manish Mahendra Choksi | Independent Director |
| Dr. Maurice Chagnaud | Independent Director |
| Mr. Nikhil Khattau | Independent Director |
| Ms. Ameera Shah | Independent Director |
| Ms. Nayantara Bali | Independent Director |
Torrent Pharmaceuticals Forecast
Price Estimates
Torrent Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-10-25 | Quarterly Results | |
| 2024-07-23 | Quarterly Results | |
| 2024-05-24 | Audited Results & Final Dividend | |
| 2024-02-02 | Quarterly Results & Interim Dividend | |
| 2023-10-23 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-06-21 | FINAL | Rs.6.00 per share(120%)Final Dividend |
| 2024-02-12 | INTERIM | Rs.22.00 per share(440%)Interim Dividend |
| 2023-06-23 | FINAL | Rs.8.00 per share(160%)Final Dividend |
| 2023-02-03 | INTERIM | Rs.14.00 per share(280%)Interim Dividend |
| 2022-06-06 | FINAL | Rs.8.00 per share(160%)Final Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2022-07-11 | Bonus | Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 5/-. |
About Torrent Pharmaceuticals
Torrent Pharmaceuticals FAQs
What is Share Price of Torrent Pharmaceuticals ?
Torrent Pharmaceuticals share price is ₹3,184 As on 06 November, 2024 | 02:39
What is the Market Cap of Torrent Pharmaceuticals ?
The Market Cap of Torrent Pharmaceuticals is ₹107766.1 Cr As on 06 November, 2024 | 02:39
What is the P/E ratio of Torrent Pharmaceuticals ?
The P/E ratio of Torrent Pharmaceuticals is 59.8 As on 06 November, 2024 | 02:39
What is the PB ratio of Torrent Pharmaceuticals ?
The PB ratio of Torrent Pharmaceuticals is 15.7 As on 06 November, 2024 | 02:39
What were the company's most recent reported sales and net income?
Torrent Pharmaceuticals Ltd recorded a net sales of INR 8508 crores in the year ending March 2022.
What is the future of the company's shares?
Torrent Pharmaceuticals Ltd stock is a good option for long-term investment since the stock prices indicate a strong buying trend.
How to buy shares of Torrent Pharmaceuticals Ltd.?
The company's shares can be bought online by opening a demat account with 5paisa and verifying the KYC documents. You can also use our mobile app for a fast experience.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.